CIP
CNMD icon

Champlain Investment Partners’s CONMED CNMD Stock Holding History

Champlain Investment Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-835,854
Closed -$43.5M – 137
2025
Q2 		$43.5M Sell
835,854
-206,511
-20% -$11.3M 0.3% 115
2025
Q1 		$62.9M Sell
1,042,365
-258,193
-20% -$16.6M 0.46% 92
2024
Q4 		$89M Sell
1,300,558
-67,092
-5% -$4.68M 0.56% 72
2024
Q3 		$98.4M Buy
1,367,650
+81,970
+6% +$5.78M 0.59% 72
2024
Q2 		$89.1M Sell
1,285,680
-17,380
-1% -$1.27M 0.55% 76
2024
Q1 		$104M Buy
1,303,060
+345,735
+36% +$30.8M 0.6% 70
2023
Q4 		$105M Buy
957,325
+14,065
+1% +$1.45M 0.62% 67
2023
Q3 		$95.1M Sell
943,260
-1,110
-0.1% -$128K 0.62% 66
2023
Q2 		$128M Sell
944,370
-39,170
-4% -$4.78M 0.79% 53
2023
Q1 		$102M Sell
983,540
-292,370
-23% -$28.3M 0.64% 71
2022
Q4 		$113M Sell
1,275,910
-42,410
-3% -$3.52M 0.73% 61
2022
Q3 		$106M Sell
1,318,320
-17,535
-1% -$1.65M 0.72% 63
2022
Q2 		$128M Sell
1,335,855
-37,150
-3% -$4.46M 0.83% 47
2022
Q1 		$204M Sell
1,373,005
-121,630
-8% -$17M 1.06% 31
2021
Q4 		$212M Buy
1,494,635
+2,216
+0.1% +$314K 0.96% 37
2021
Q3 		$195M Buy
1,492,419
+16,430
+1% +$2.15M 0.94% 37
2021
Q2 		$203M Sell
1,475,989
-228,950
-13% -$31.3M 0.96% 36
2021
Q1 		$223M Buy
1,704,939
+12,925
+0.8% +$1.56M 1.16% 29
2020
Q4 		$190M Buy
1,692,014
+125,290
+8% +$11.9M 1.09% 35
2020
Q3 		$123M Buy
1,566,724
+101,565
+7% +$8.28M 0.84% 50
2020
Q2 		$105M Buy
1,465,159
+187,964
+15% +$13.1M 0.76% 53
2020
Q1 		$73.1M Buy
1,277,195
+151,655
+13% +$14M 0.66% 63
2019
Q4 		$126M Sell
1,125,540
-184,900
-14% -$19.7M 0.92% 44
2019
Q3 		$126M Sell
1,310,440
-141,920
-10% -$13.3M 1.04% 40
2019
Q2 		$124M Buy
1,452,360
+19,025
+1% +$1.56M 1.04% 39
2019
Q1 		$119M Buy
1,433,335
+11,155
+0.8% +$810K 1.04% 39
2018
Q4 		$91.3M Buy
1,422,180
+46,525
+3% +$3.18M 0.93% 48
2018
Q3 		$109M Buy
1,375,655
+40,100
+3% +$3.1M 0.97% 41
2018
Q2 		$97.8M Buy
1,335,555
+13,450
+1% +$915K 0.95% 43
2018
Q1 		$83.7M Sell
1,322,105
-155,365
-11% -$9.28M 0.91% 45
2017
Q4 		$75.3M Sell
1,477,470
-182,710
-11% -$9.52M 0.85% 48
2017
Q3 		$87.1M Sell
1,660,180
-87,336
-5% -$4.38M 1.03% 36
2017
Q2 		$89M Buy
1,747,516
+19,071
+1% +$944K 1.09% 32
2017
Q1 		$76.8M Buy
1,728,445
+243,610
+16% +$10.5M 1.01% 34
2016
Q4 		$65.6M Sell
1,484,835
-18,645
-1% -$792K 0.91% 36
2016
Q3 		$60.2M Buy
1,503,480
+37,840
+3% +$1.61M 0.91% 37
2016
Q2 		$70M Buy
1,465,640
+556,060
+61% +$23.5M 1.21% 23
2016
Q1 		$38.1M Buy
909,580
+460,885
+103% +$18.1M 0.69% 63
2015
Q4 		$19.8M Buy
+448,695
New +$19.5M 0.34% 108

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Champlain Investment Partners's CNMD Position: Q3 2025 in Review

Champlain Investment Partners sold out of CONMED (CNMD) in Q3 2025, closing a stake of 835,854 shares — an estimated $43.5M sold.

Champlain Investment Partners first reported a position in CNMD in Q4 2015 and held it in 39 quarters. The position peaked at $223M in Q1 2021. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Champlain Investment Partners reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Champlain Investment Partners sold 835,854 CONMED shares in Q3 2025, an estimated $43.5M.
  • Champlain Investment Partners first reported a position in CONMED in Q4 2015 and held it in 39 quarters.
  • Champlain Investment Partners's CONMED position peaked at $223M in Q1 2021.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Champlain Investment Partners's 13F filing for Q3 2025, filed 12 Nov 2025.